NDTV-Dettol Banega Swasth Swachh India NDTV-Dettol Banega Swasth Swachh India
  • Home/
  • Coronavirus Vaccine/
  • Bharat Biotech’s Nasal COVID Vaccine For Adults Gets Centre’s Nod, To Be Availabile In Private Hospitals

Coronavirus Vaccine

Bharat Biotech’s Nasal COVID Vaccine For Adults Gets Centre’s Nod, To Be Availabile In Private Hospitals

The vaccine will be available in private hospitals and will be included in the COVID-19 vaccination programs from December 23. The CoWIN platform will also be modified in this regard

Bharat Biotech's Nasal COVID Vaccine For Adults Gets Centre's Nod, To Be Availabile In Private Hospitals
The vaccine will be available on the CoWIN app starting December 23

New Delhi: The central government has approved the use of Bharat Biotech’s nasal Covid vaccine iNCOVACC to be included in the country’s vaccination programme as a booster dose for those above 18 years of age. The Union Health Ministry said that those who have taken Covishield and Covaxin can take the nasal vaccine as a heterologous booster dose.

The vaccine will be available on the CoWIN app starting December 23. The iNCOVACC has been approved by the Government of India and will be used as a heterologous booster dose for those above 18 years of age.

Also Read: Covid Vaccine Provides Substantial Protection Against Reinfection: Study

The vaccine will be available in private hospitals and will be included in the COVID-19 vaccination programs from December 23. The CoWIN platform will also be modified in this regard.

In heterologous boosting, a person administered a different vaccine from the one that was used for the primary dose series.

In November, Bharat Biotech International Limited (BBIL) announced that iNCOVACC (BBV154), has received approval from the Central Drugs Standard Control Organisation (CDSCO) under Restricted Use in Emergency Situation for ages 18 and above, in India, for heterologous booster doses.

iNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilized SARS-CoV-2 spike protein. The vaccine has been specifically formulated to allow intranasal delivery through nasal drops. The nasal delivery system has been designed and developed to be cost-effective in low- and middle-income countries.

Also Read: US Says India An Important Manufacturer Of Vaccines For World

The vaccine was developed in partnership with Washington University, St. Louis, which had designed and developed the recombinant adenoviral vectored construct and evaluated in preclinical studies for efficacy.

Product development and clinical trials were funded in part by the Government of India, through the Department of Biotechnology’s, COVID Suraksha Program.

Meanwhile, Union Health Minister Mansukh Mandaviya is scheduled to holding a virtual meeting with State health ministers on the Covid-19 situation and preparedness at 3 pm today, according to sources. Prime Minister Narendra Modi had chaired a high-level meeting yesterday to review the status and preparedness of public health response to COVID-19 and emphasised the need for strengthened surveillance with a focus on genome sequencing and increased testing.

This high-level review meeting comes against the backdrop of a spike in COVID-19 cases in some countries, according to the Prime Minister’s Office.

PM Modi assessed the COVID-19 situation in the country, the preparedness of health infrastructure and logistics and the status of the vaccination campaign in the country. He also evaluated the emergence of new Covid-19 variants and their public health implications.

Over the last two days, Chief Ministers of many states around the country have conducted high-level meetings with Senior Officials regarding the preparedness for Covid19 in their states.

The sub-variant of the Omicron variant BF.7, that is driving the new surge in Covid cases in China, Japan, South Korea, France and the United States, has been detected in India also. A total of four cases have been reported in four states in India — the first one in July and the latest in November. Overall cases in India continue to be relatively meagre, at fewer than 200 daily for several days now. As per sources, there are currently 10 different variants of Covid-19 in the country, with the latest being BF.7.

Also Read: Global Roll-Out Of 12 Billion COVID-19 Vaccine Doses Largest-Ever But Access An Issue: WHO

(This story has not been edited by NDTV staff and is published from a syndicated feed.)

NDTV – Dettol have been working towards a clean and healthy India since 2014 via the Banega Swachh India initiative, which is helmed by Campaign Ambassador Amitabh Bachchan. The campaign aims to highlight the inter-dependency of humans and the environment, and of humans on one another with the focus on One Health, One Planet, One Future – Leaving No One Behind. It stresses on the need to take care of, and consider, everyone’s health in India – especially vulnerable communities – the LGBTQ populationindigenous people, India’s different tribes, ethnic and linguistic minorities, people with disabilities, migrants, geographically remote populations, gender and sexual minorities. In wake of the current COVID-19 pandemic, the need for WASH (WaterSanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign will continue to raise awareness on the same along with focussing on the importance of nutrition and healthcare for women and children, fight malnutrition, mental wellbeing, self care, science and health, adolescent health & gender awareness. Along with the health of people, the campaign has realised the need to also take care of the health of the eco-system. Our environment is fragile due to human activity, which is not only over-exploiting available resources, but also generating immense pollution as a result of using and extracting those resources. The imbalance has also led to immense biodiversity loss that has caused one of the biggest threats to human survival – climate change. It has now been described as a “code red for humanity.” The campaign will continue to cover issues like air pollutionwaste managementplastic banmanual scavenging and sanitation workers and menstrual hygiene. Banega Swasth India will also be taking forward the dream of Swasth Bharat, the campaign feels that only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diarrhoea and the country can become a Swasth or healthy India.

Highlights: Banega Swasth India Launches Season 10

Reckitt’s Commitment To A Better Future

India’s Unsung Heroes

Women’s Health

हिंदी में पढ़ें

This website follows the DNPA Code of Ethics

© Copyright NDTV Convergence Limited 2024. All rights reserved.